Evaluation of Serum Prostate Specific Antigen in Diagnosis of Patients with Prostate Cancer

Serum PSA level in patients with urogenital disorders was measured by PSA kits using monoclonal antibody. Serum PSA values in 122 healthy men were 1.1 ± 0.3 ng/ml (mean ± S.D. ) and upper limit of mean+2 S.D. in healthy men was 1.7 ng/ml. Serum PSA levels in 15 male patients with prostate cancer wer...

Full description

Saved in:
Bibliographic Details
Published inRADIOISOTOPES Vol. 40; no. 7; pp. 298 - 301
Main Authors TUDA, Takaaki, HIRANO, Atuyuki, UEKADO, Yasunari, KUMAYAMA, Yoshitaka, HAGINO, Keizo, MORITA, Teruo, OTA, Kiichiro, TORIZUMI, Kazutami, MIYAI, Masahiro
Format Journal Article
LanguageJapanese
Published Japan Radioisotope Association 15.07.1991
Subjects
immunoradiometric assay
prostate cancer
prostate specific antigen
Online AccessGet full text
ISSN0033-8303
1884-4111
DOI10.3769/radioisotopes.40.7_298

Cover

More Information
Summary:Serum PSA level in patients with urogenital disorders was measured by PSA kits using monoclonal antibody. Serum PSA values in 122 healthy men were 1.1 ± 0.3 ng/ml (mean ± S.D. ) and upper limit of mean+2 S.D. in healthy men was 1.7 ng/ml. Serum PSA levels in 15 male patients with prostate cancer were more increased than those in 11 male patients with prostate hypertrophy (556.9±896.1 ng/ml vs. 8.4±10.4 ng/ml, p<0.001) . It is our conclusion that the estimate of serum PSA level provided a useful diagnostic information of prostate cancer.
ISSN:0033-8303
1884-4111
DOI:10.3769/radioisotopes.40.7_298